Alnylam Pharmaceuticals, Inc. (ALNY)

CIK 1178670 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Alnylam Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 20268-K0001178670-26-000080
Nov 5, 2026SCHEDULE 13G/A0000315066-26-002695
Oct 30, 2026SCHEDULE 13G0002100121-26-001039
Oct 29, 202610-Q0001178670-26-000076
Oct 29, 20268-K0001178670-26-000074
Oct 6, 202640001178670-26-000068
Oct 2, 20261440001959173-26-007216
Sep 22, 202640001178670-26-000065
Jul 30, 20268-K0001178670-26-000060
Jul 30, 202610-Q0001178670-26-000062
Jun 3, 202630001178670-26-000046
Jun 3, 202640001178670-26-000047
Jun 3, 202640001178670-26-000048
Jun 1, 20261440001969223-26-000618
May 27, 20268-K0001628280-26-038499
May 22, 202640001178670-26-000034
May 22, 202640001178670-26-000042
May 22, 202640001178670-26-000041
May 22, 202640001178670-26-000036
May 22, 202640001178670-26-000035
May 22, 202640001178670-26-000037
May 22, 202640001178670-26-000039
May 22, 202640001178670-26-000038
May 22, 202640001178670-26-000040
May 14, 2026SCHEDULE 13G/A0001422849-26-000061